Hello, Fool! | Login | Signup | My Fool
Oct 8, 2008 2:01 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company that develops novel drugs for pain management and oncology.
View Ticker Page (PTIE)
Results 1 - 10 of 29 : 123
Recs
NetscribeBiotech (88.86) Submitted: 5/30/07 7:04 AM : Start Price: $8.35 PTIE Score: -40.42
The world pain management market is growing at a brisk pace and any company that is ready with a compound to tap this growing market has all reasons to cheer. Having said that Pain Therapeutics, which develops drugs catering to this segment as well a...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Knifecatcher1 (< 20) Submitted: 11/05/06 8:30 PM : Start Price: $8.16 PTIE Score: 35.91
Remoxy phase 3 trial is as close to a lock for success as is possible in the pharmaceutical sector (in 2007). Remoxy acts as a non-dissolvable, non-crushable form of oxycodone that is extremely difficult to misuse. The above from: www.fool.com/N...
greenwavenick (77.83) Submitted: 1/25/07 7:08 PM : Start Price: $8.65 PTIE Score: 32.00
PTIE specializes in non-addictive, tamper proof opiods. They have three drugs in the pipeline including one, Oxytrex, that just began Phase III of FDA Approval and another, Remoxy, that is farther along in them. Additionally, PTI-202 just succesfully...
chgas12 (< 20) Submitted: 11/29/06 4:57 PM : Start Price: $8.65 PTIE Score: 31.53
Likely approval of narcotic analgesics with less abuse potential. Fills a hugh need.
chazzzzz2 (44.87) Submitted: 4/27/07 5:37 PM : Start Price: $7.89 PTIE Score: 45.83
Oxytrex or Remoxy take you pick. Enough cash on hand to last several years. Data could be out by fall for Remoxy and shortly thereafter for Oxytrex. Best play is the JAN09 calls. Gives you a year and a half to wait it out
ACPdiddy (92.67) Submitted: 2/26/07 2:45 PM : Start Price: $8.07 PTIE Score: 41.24
Two products in phase 3 clinical trials for pain which is a very large market. Both of these products are variations on currently marketed painkillers so there is a high probability that the trials will be successful (one is an abuse-resistant varia...
myguess33 (< 20) Submitted: 6/01/07 11:35 PM : Start Price: $7.62 PTIE Score: 45.49
A risk I am willing to take. Company has made a stock buyback...King pharma has funded it as the vehicle for their future in opioids. The company is profitable. Read the insight from Lawler(Fool) and Shade(seekingalpha) as well as biohealthinvestor. ...
JiminyBillyBob (32.42) Submitted: 2/25/08 3:57 AM : Start Price: $9.01 PTIE Score: 24.87
Tons of cash and no long term debt. While this company's prospects depend on future FDA approvals, it has enough of a cushion courtesy of King Pharmaceuticals in case things do not go as planned. Even risk-adverse investors should take a look at th...
bddoyl1 (< 20) Submitted: 4/05/07 3:00 PM : Start Price: $8.05 PTIE Score: 41.13
new products
AtomicDoom (88.39) Submitted: 7/01/07 10:18 PM : Start Price: $8.79 PTIE Score: 34.84
Fundamentals are awesome if they can keep it up. Highly undervalued.
Terms & Conditions
RSS Headlines
Fool UK